Literature DB >> 1765893

Treating cigarette smoking in methadone maintenance clients.

J Story1, M J Stark.   

Abstract

Substance abusers in treatment have cigarette-smoking rates about three times that found in the general adult population, yet there is a paucity of published studies examining smoking-cessation programs for these clients. Accordingly, a behaviorally based smoking-cessation program for methadone maintenance clients was developed, and the efficacy of a methadone dose increase as a pharmacological adjunct was tested in a double-blind placebo-controlled study. While no significant difference between experimental and control subjects in reported abstinence rates was found, subjects receiving a methadone increase reported significantly more nicotine craving and other withdrawal symptoms during the first week of abstinence than did controls. Measures of smoking rates indicated that experimental subjects smoked significantly more than controls throughout the 10-week study period. Although the initial smoking abstinence rate of 65% was encouraging, most subjects returned to smoking by the end of the study period. These findings indicate that the development of smoking-cessation programs for methadone clients merits further study and that such programs should stress relapse prevention techniques tailored to the specific needs of this population. Also, while the use of a methadone dose increase as a pharmacological adjunct has not been found to be efficacious, other pharmacological strategies involving the use of nicotine should not be ruled out.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1765893     DOI: 10.1080/02791072.1991.10472237

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  22 in total

1.  Early quit days among methadone-maintained smokers in a smoking cessation trial.

Authors:  Marcel A de Dios; Bradley J Anderson; Celeste M Caviness; Michael D Stein
Journal:  Nicotine Tob Res       Date:  2014-06-20       Impact factor: 4.244

2.  Perceived stress and substance use in methadone-maintained smokers.

Authors:  Ethan Moitra; Bradley J Anderson; Michael D Stein
Journal:  Drug Alcohol Depend       Date:  2013-08-26       Impact factor: 4.492

3.  Investigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities.

Authors:  Joanna M Streck; Stacey C Sigmon; Jeffrey Priest; Cecilia L Bergeria; Danielle R Davis; John R Hughes; Andrea C Villanti; Jennifer W Tidey; Sarah H Heil; Diann E Gaalema; Maxine L Stitzer; Stephen T Higgins
Journal:  Exp Clin Psychopharmacol       Date:  2020-02-06       Impact factor: 3.157

4.  Contingency management for behavior change: applications to promote brief smoking cessation among opioid-maintained patients.

Authors:  Kelly E Dunn; Kathryn A Saulsgiver; Stacey C Sigmon
Journal:  Exp Clin Psychopharmacol       Date:  2011-02       Impact factor: 3.157

Review 5.  Co-morbidity of smoking in patients with psychiatric and substance use disorders.

Authors:  David Kalman; Sandra Baker Morissette; Tony P George
Journal:  Am J Addict       Date:  2005 Mar-Apr

Review 6.  Achieving Smoking Cessation Among Persons with Opioid Use Disorder.

Authors:  Cynthia Vlad; Julia H Arnsten; Shadi Nahvi
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

7.  An Open Trial of Electronic Cigarettes for Smoking Cessation Among Methadone-Maintained Smokers.

Authors:  Michael D Stein; Celeste Caviness; Kristin Grimone; Daniel Audet; Bradley J Anderson; Genie L Bailey
Journal:  Nicotine Tob Res       Date:  2015-12-28       Impact factor: 4.244

8.  Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial.

Authors:  M D Stein; C M Caviness; M E Kurth; D Audet; J Olson; B J Anderson
Journal:  Drug Alcohol Depend       Date:  2013-08-14       Impact factor: 4.492

9.  Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement.

Authors:  Rosemarie A Martin; Damaris J Rohsenow; Jennifer W Tidey
Journal:  J Subst Abuse Treat       Date:  2019-06-10

10.  Preliminary study of buprenorphine and bupropion for opioid-dependent smokers.

Authors:  Marc E Mooney; James Poling; Gerardo Gonzalez; Kishor Gonsai; Thomas Kosten; Mehmet Sofuoglu
Journal:  Am J Addict       Date:  2008 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.